Emma Wilkinson speaks to GPs across England as they raise the alarm over a chaotic rollout of weight-loss drug Mounjaro on ...

Researchers have found that GP pay for performance, such as QOF, is not a ‘magic bullet’ to improving quality.

I’ve always argued that, come the inevitable AI medical revolution, GPs will be last against the wall. This horticultural epiphany suggests otherwise. If AI can correctly diagnose ...

GPs have been urged to be vigilant to signs of acute pancreatitis in patients who are taking GLP-1 weight-loss drugs.

The BMA in Scotland has moved into ‘formal dispute’ with the Government over years of underfunding, it has announced today.

GPs may only encounter once in their career, GP dermatology specialist Dr Anna Trigell explains how not to miss a case of ...

GP in many parts of England are having explain to eligible patients that tirzepatide (Mounjaro) cannot be prescribed in ...

Factors such as a practice’s dispensing status account for variation in repeat prescription lengths, new data from the BJGP suggests.

GPs working for a private company have been told they will not be paid for shifts completed in the last month.

The upcoming 10-year plan for health will include a review of the Carr-Hill formula for GP funding, the Government has said.

Editor Sofia Lind questions the lack of planning, support and infrastructure for GPs among the rollout of tirzepatide in ...

Patients with both chronic kidney disease (CKD) and type 2 diabetes may benefit from therapy with finerenone and ...